| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
Review article |
Department of Biochemistry, Purdue University, West Lafayette, IN 47907-1153, USA
Correspondence
Steven Broyles
broyles{at}purdue.edu
Vaccinia virus replication takes place in the cytoplasm of the host cell. The nearly 200 kbp genome owes part of its complexity to encoding most of the proteins involved in genome and mRNA synthesis. The multisubunit vaccinia virus RNA polymerase requires a separate set of virus-encoded proteins for the transcription of the early, intermediate and late classes of genes. Cell fractionation studies have provided evidence for a role for host cell proteins in the initiation and termination of vaccinia virus intermediate and late gene transcription. Vaccinia virus resembles nuclear DNA viruses in the integration of viral and host proteins for viral mRNA synthesis, yet is markedly less reliant on host proteins than its nuclear counterparts.
Published ahead of print on 28 May 2003 as DOI 10.1099/vir.0.18942-0
This article has been cited by other articles:
|
|
 |
|
  E. Assarsson, J. A. Greenbaum, M. Sundstrom, L. Schaffer, J. A. Hammond, V. Pasquetto, C. Oseroff, R. C. Hendrickson, E. J. Lefkowitz, D. C. Tscharke, et al. Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes PNAS, February 12, 2008; 105(6): 2140 - 2145. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Myskiw, Y. Deschambault, K. Jefferies, R. He, and J. Cao Aurintricarboxylic Acid Inhibits the Early Stage of Vaccinia Virus Replication by Targeting both Cellular and Viral Factors J. Virol., March 15, 2007; 81(6): 3027 - 3032. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Brown, T. G. Senkevich, and B. Moss Vaccinia Virus F9 Virion Membrane Protein Is Required for Entry but Not Virus Assembly, in Contrast to the Related L1 Protein J. Virol., October 1, 2006; 80(19): 9455 - 9464. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. A. Knutson, X. Liu, J. Oh, and S. S. Broyles Vaccinia Virus Intermediate and Late Promoter Elements Are Targeted by the TATA-Binding Protein J. Virol., July 15, 2006; 80(14): 6784 - 6793. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Rahbar, T. T. Murooka, A. A. Hinek, C. L. Galligan, A. Sassano, C. Yu, K. Srivastava, L. C. Platanias, and E. N. Fish Vaccinia Virus Activation of CCR5 Invokes Tyrosine Phosphorylation Signaling Events That Support Virus Replication J. Virol., July 15, 2006; 80(14): 7245 - 7259. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. L. Najera, C. E. Gomez, E. Domingo-Gil, M. M. Gherardi, and M. Esteban Cellular and Biochemical Differences between Two Attenuated Poxvirus Vaccine Candidates (MVA and NYVAC) and Role of the C7L Gene. J. Virol., June 1, 2006; 80(12): 6033 - 6047. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Ludwig, Y. Suezer, Z. Waibler, U. Kalinke, B. S. Schnierle, and G. Sutter Double-stranded RNA-binding protein E3 controls translation of viral intermediate RNA, marking an essential step in the life cycle of modified vaccinia virus Ankara. J. Gen. Virol., May 1, 2006; 87(Pt 5): 1145 - 1155. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Parrish and B. Moss Characterization of a Vaccinia Virus Mutant with a Deletion of the D10R Gene Encoding a Putative Negative Regulator of Gene Expression J. Virol., January 15, 2006; 80(2): 553 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Resch and B. Moss The Conserved Poxvirus L3 Virion Protein Is Required for Transcription of Vaccinia Virus Early Genes J. Virol., December 1, 2005; 79(23): 14719 - 14729. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Gherardi and M. Esteban Recombinant poxviruses as mucosal vaccine vectors J. Gen. Virol., November 1, 2005; 86(11): 2925 - 2936. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Oh and S. S. Broyles Host Cell Nuclear Proteins Are Recruited to Cytoplasmic Vaccinia Virus Replication Complexes J. Virol., October 15, 2005; 79(20): 12852 - 12860. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Ludwig, J. Mages, C. Staib, M. H. Lehmann, R. Lang, and G. Sutter Role of Viral Factor E3L in Modified Vaccinia Virus Ankara Infection of Human HeLa Cells: Regulation of the Virus Life Cycle and Identification of Differentially Expressed Host Genes J. Virol., February 15, 2005; 79(4): 2584 - 2596. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. C. Katsafanas and B. Moss Vaccinia Virus Intermediate Stage Transcription Is Complemented by Ras-GTPase-activating Protein SH3 Domain-binding Protein (G3BP) and Cytoplasmic Activation/Proliferation-associated Protein (p137) Individually or as a Heterodimer J. Biol. Chem., December 10, 2004; 279(50): 52210 - 52217. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. C. Harrison, B. Alberts, E. Ehrenfeld, L. Enquist, H. Fineberg, S. L. McKnight, B. Moss, M. O'Donnell, H. Ploegh, S. L. Schmid, et al. Perspective: Discovery of antivirals against smallpox PNAS, August 3, 2004; 101(31): 11178 - 11192. [Full Text] [PDF]
|
|
|
|
|
|
S. S. Broyles, M. Kremer, and B. A. Knutson Antiviral Activity of Distamycin A against Vaccinia Virus Is the Result of Inhibition of Postreplicative mRNA Synthesis J. Virol., February 15, 2004; 78(4): 2137 - 2141. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| INT J SYST EVOL MICROBIOL | MICROBIOLOGY | J GEN VIROL |
| J MED MICROBIOL | ALL SGM JOURNALS | |
